Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a note issued to investors on Sunday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Global Cord Blood stock opened at $0.80 on Friday. The company has a market cap of $97.24 million, a P/E ratio of 1.25 and a beta of 0.16. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The business has a fifty day moving average of $0.95 and a two-hundred day moving average of $1.22.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.